quem é dra maria isabel barillas de goldstein

Quem é dra maria isabel barillas de goldstein

doi: 10.1111/anae.15563. Epub 2021 Aug 24.

Collaborators, Affiliations

  • PMID: 34428858
  • PMCID: PMC8652887
  • DOI: 10.1111/anae.15563

Free PMC article

SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study

COVIDSurg Collaborative et al. Anaesthesia. 2022 Jan.

Free PMC article

Abstract

SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in critically ill patients. Since surgical patients are already at higher risk of venous thromboembolism than general populations, this study aimed to determine if patients with peri-operative or prior SARS-CoV-2 were at further increased risk of venous thromboembolism. We conducted a planned sub-study and analysis from an international, multicentre, prospective cohort study of elective and emergency patients undergoing surgery during October 2020. Patients from all surgical specialties were included. The primary outcome measure was venous thromboembolism (pulmonary embolism or deep vein thrombosis) within 30 days of surgery. SARS-CoV-2 diagnosis was defined as peri-operative (7 days before to 30 days after surgery); recent (1-6 weeks before surgery); previous (≥7 weeks before surgery); or none. Information on prophylaxis regimens or pre-operative anti-coagulation for baseline comorbidities was not available. Postoperative venous thromboembolism rate was 0.5% (666/123,591) in patients without SARS-CoV-2; 2.2% (50/2317) in patients with peri-operative SARS-CoV-2; 1.6% (15/953) in patients with recent SARS-CoV-2; and 1.0% (11/1148) in patients with previous SARS-CoV-2. After adjustment for confounding factors, patients with peri-operative (adjusted odds ratio 1.5 (95%CI 1.1-2.0)) and recent SARS-CoV-2 (1.9 (95%CI 1.2-3.3)) remained at higher risk of venous thromboembolism, with a borderline finding in previous SARS-CoV-2 (1.7 (95%CI 0.9-3.0)). Overall, venous thromboembolism was independently associated with 30-day mortality (5.4 (95%CI 4.3-6.7)). In patients with SARS-CoV-2, mortality without venous thromboembolism was 7.4% (319/4342) and with venous thromboembolism was 40.8% (31/76). Patients undergoing surgery with peri-operative or recent SARS-CoV-2 appear to be at increased risk of postoperative venous thromboembolism compared with patients with no history of SARS-CoV-2 infection. Optimal venous thromboembolism prophylaxis and treatment are unknown in this cohort of patients, and these data should be interpreted accordingly.

Keywords: COVID-19; SARS-CoV-2; deep vein thrombosis; pulmonary embolism; venous thromboembolism.

© 2021 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists.

Figures

Figure 1

Flow diagram of patients showing venous thromboembolism (VTE), pneumonia, mortality and SARS‐CoV‐2 infection.

Figure 2

Forest plot of adjusted regression model for factors associated with venous thromboembolism. Figures show the reference value (Ref) and OR (95%CI) for the levels of each variable.

Figure 3

Adjusted sub‐group analysis for venous thromboembolism in (A) elective and emergency patients and (B) major and minor surgery patients. Sub‐group analyses are adjusted for the following variables: pneumonia; age; sex; ASA physical status; smoker; respiratory comorbidities; congestive heart failure; cerebral vascular disease; chronic kidney disease; ischaemic heart disease; indication; grade; urgency; anaesthesia; and country income. Full details can be found in online Supporting Information Tables S4 to S7. Figures show the reference value (Ref) and OR (95%CI) for the levels of each variable.

Figure 4

Venous thromboembolism (VTE) and 30‐day mortality in patients with pre‐operative SARS‐CoV‐2 by presence or absence of COVID‐19 symptoms.

Similar articles

  • Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study.

    COVIDSurg Collaborative; GlobalSurg Collaborative. COVIDSurg Collaborative, et al. Anaesthesia. 2021 Jun;76(6):748-758. doi: 10.1111/anae.15458. Epub 2021 Mar 9. Anaesthesia. 2021. PMID: 33690889 Free PMC article.

  • ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study.

    Ray JG, Vermeulen MJ, Schull MJ, Park AL. Ray JG, et al. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211008986. doi: 10.1177/10760296211008986. Clin Appl Thromb Hemost. 2021. PMID: 33827287 Free PMC article. No abstract available.

  • Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.

    COVIDSurg Collaborative; GlobalSurg Collaborative. COVIDSurg Collaborative, et al. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560. Epub 2021 Aug 9. Anaesthesia. 2021. PMID: 34371522 Clinical Trial.

  • Incidence and risk factors for venous thromboembolism events after different routes of pelvic organ prolapse repairs.

    Chong W, Bui AH, Menhaji K. Chong W, et al. Am J Obstet Gynecol. 2020 Aug;223(2):268.e1-268.e26. doi: 10.1016/j.ajog.2020.05.020. Epub 2020 May 13. Am J Obstet Gynecol. 2020. PMID: 32413430

  • Anticoagulants for people hospitalised with COVID-19.

    Flumignan RL, Civile VT, Tinôco JDS, Pascoal PI, Areias LL, Matar CF, Tendal B, Trevisani VF, Atallah ÁN, Nakano LC. Flumignan RL, et al. Cochrane Database Syst Rev. 2022 Mar 4;3(3):CD013739. doi: 10.1002/14651858.CD013739.pub2. Cochrane Database Syst Rev. 2022. PMID: 35244208 Review.

Cited by

  • Thrombosis and lymphocyte subsets of COVID-19 omicron BA.2 variant patients with cancer.

    Yin J, Cong X, Wang N, Song W, Guan Y, Zhang Y, Li Z, Liu Z. Yin J, et al. Front Oncol. 2022 Nov 10;12:1048999. doi: 10.3389/fonc.2022.1048999. eCollection 2022. Front Oncol. 2022. PMID: 36439504 Free PMC article.

  • Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.

    Amaral FC, Baptista-Silva JC, Nakano LC, Flumignan RL. Amaral FC, et al. Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2. Cochrane Database Syst Rev. 2022. PMID: 36413425 Review.

  • Antagonism of Rhizosphere Streptomyces yangpuensis CM253 against the Pathogenic Fungi Causing Corm Rot in Saffron (Crocus sativus L.).

    Tian L, Hu S, Wang X, Guo Y, Huang L, Wang L, Li W. Tian L, et al. Pathogens. 2022 Oct 16;11(10):1195. doi: 10.3390/pathogens11101195. Pathogens. 2022. PMID: 36297252 Free PMC article.

  • Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review.

    Nappi F, Nappi P, Gambardella I, Avtaar Singh SS. Nappi F, et al. Metabolites. 2022 Sep 22;12(10):889. doi: 10.3390/metabo12100889. Metabolites. 2022. PMID: 36295791 Free PMC article. Review.

  • Southern Carpathian ultramafic grasslands within the central-southeast European context: syntaxonomic classification and overall eco-coenotic patterns.

    Coldea G, Gafta D, Negrean G, Stoica AI, Hurdu BI. Coldea G, et al. Bot Stud. 2022 Oct 12;63(1):29. doi: 10.1186/s40529-022-00355-8. Bot Stud. 2022. PMID: 36222902 Free PMC article.

References

    1. Longchamp G, Manzocchi‐Besson S, Longchamp A, Righini M, Robert‐Ebadi H, Blondon M. Proximal deep vein thrombosis and pulmonary embolism in COVID‐19 patients: a systematic review and meta‐analysis. Thrombosis Journal 2021; 19: 15. - PMC - PubMed
    1. Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis. Research and Practice in Thrombosis and Haemostasis 2020; 4: 1178–91. - PMC - PubMed
    1. Al‐Ani F, Chehade S, Lazo‐Langner A. Thrombosis risk associated with COVID‐19 infection. A scoping review. Thrombosis Research 2020; 192: 152–60. - PMC - PubMed
    1. Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AW, Di Nisio M. Venous thromboembolism in patients with COVID‐19: systematic review and meta‐analysis. Thrombosis Research 2020; 196: 67–74. - PMC - PubMed
    1. Potere N, Valeriani E, Candeloro M, et al. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta‐analysis. Critical Care 2020; 24: 389. - PMC - PubMed

MeSH terms

Grant support

  • 2018RIF_06/PANCREATICCANUK_/Pancreatic Cancer UK/United Kingdom
  • CH/17/1/32804/BHF_/British Heart Foundation/United Kingdom
  • PG/15/33/31394/BHF_/British Heart Foundation/United Kingdom
  • T32 DK060442/DK/NIDDK NIH HHS/United States

LinkOut - more resources

  • Full Text Sources

    • Bern Open Repository and Information System
    • Europe PubMed Central
    • Ovid Technologies, Inc.
    • PubMed Central
    • White Rose Research Online
    • Wiley

  • Other Literature Sources

    • Faculty Opinions

  • Medical

    • Genetic Alliance
    • MedlinePlus Health Information

  • Miscellaneous

    • NCI CPTAC Assay Portal

Postagens relacionadas

Qual o principal tipo de indústria da primeira revolução industrial?
O que é o Anak Krakatoa
Como as cooperativas podem ajudar uma população local ou um grupo de pessoas?
Mensagem romântica de bom dia
O que fazer para parar de tossir em 1 dia?
Quais os fatores que contribuíram para o fracasso do sistema de capitanias no Brasil?
Sintomas de menstruação e não desce
Quando saímos do banho ou da piscina com o corpo ainda molhado temos a sensação de frio mesmo em dias de temperaturas?
O estudo dos determinantes sociais de saúde visa a melhorar as condições de saúde da população
Como baixar a pressão arterial de forma natural

Toplist

Última postagem

Tag

Q&a Tips O que Como Tecnologia Eth Crio Ios Que é qual Por que Popular Onde Por que quantos Comparar Quando Oppo Quem Importância quanto Comparação Melhor Apple Top List Diferença entre Média Excel Cryto Google Lg Top Iphone List Monitor Máquina Teclado Mais popular cujo Dicas Guia Ipad Samsung Sinal Arquivo